Global Point-of-Care Infectious Disease Diagnostics or Testing Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026

SKU ID :Maia-14657146 | Published Date: 05-Mar-2020 | No. of pages: 109
The Point-of-Care Infectious Disease Diagnostics or Testing market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Point-of-Care Infectious Disease Diagnostics or Testing market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Point-of-Care Infectious Disease Diagnostics or Testing market. The report focuses on well-known providers in the global Point-of-Care Infectious Disease Diagnostics or Testing industry, market segments, competition, and the macro environment.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Point-of-Care Infectious Disease Diagnostics or Testing market covered in Chapter 4:
BD & Company
Ortho-Clinical Diagnostic
Trivitron Healthcare
Siemens Healthineers
Sight Diagnostics Ltd.
Bio-Rad Labs Inc.
bioMérieux SA
Chembio Diagnostics Inc
OJ-Bio Ltd.
Trinity Biotech
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Gene POC
Quest Diagnostics, Inc
Alere
Cardinal Health

In Chapter 11 and 13.3, on the basis of types, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2015 to 2026 is primarily split into:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Other infectious disease POC

In Chapter 12 and 13.4, on the basis of applications, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2015 to 2026 covers:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:


Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2026
  • PRICE
  • $3400
    $6200
    Buy Now

Our Clients